The Latest Cardiac and Vascular News
Round Led by Sonder Capital with Participation from Senvest Management, LB Investment, and a New Strategic Corporate Investor MENLO PARK, Calif. – October 7, 2025 – Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using its proprietary Transforming Fixation (TFX) technology, today announced it has […]
Jupiter Endovascular’s Vertex™ Catheter just received 510(k) clearance for the insertion of endovascular devices. This technology adopts Transforming Fixation (TFX) — able to shift from flexible to firm on demand, giving physicians true stability and control. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K252027
MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup transforming endovascular medicine with a new class of interventions, announced today that experienced medtech finance and operations executive Fred Ong has joined the company as Chief Financial Officer. “Fred is joining us at a pivotal time as we build upon […]
MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™, announced today that the first U.S. patient has been treated in the SPIRARE II U.S. pivotal study of the Vertex Pulmonary Embolectomy System featuring the company’s Endoportal Control™ platform technology. […]
MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™, announced today that the first two patients have been treated in SPIRARE I (NCT06571760), a multicenter study of the Vertex Pulmonary Embolectomy System using the company’s Endoportal Control™ platform technology. […]
August 29, 2024 08:00 AM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal Control™ to bring the precision and control of direct surgical access to catheter-based interventions, announced today that the U.S. Food and Drug Administration (FDA) has […]
August 15, 2024 10:00 AM Eastern Daylight Time MENLO PARK, Calif.–(BUSINESS WIRE)–Jupiter Endovascular, Inc., a medical technology startup developing a new class of endovascular procedures using Endoportal ControlTM to bring the precision and control of direct surgical access to catheter-based interventions, announced today that it has exited stealth mode with a […]
